Related Experiment Videos
Animal models of hypertrophic cardiomyopathy
1Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder 80309, USA.
Insights
Familial hypertrophic cardiomyopathy (FHC) is a genetic heart disease caused by sarcomere gene mutations. Research uses in vitro studies and animal models to understand FHC pathogenesis and develop targeted therapies.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Diseases
Background:
- Familial hypertrophic cardiomyopathy (FHC) is an autosomal-dominant, heterogeneous genetic disorder affecting the heart's sarcomere.
- Mutations in eight genes encoding sarcomeric proteins cause FHC, leading to diverse clinical phenotypes that are not fully understood.
Purpose of the Study:
- To investigate the pathogenesis of familial hypertrophic cardiomyopathy (FHC).
- To explore the functional deficits of mutant sarcomeric protein alleles.
- To utilize animal models for a deeper understanding of FHC disease mechanisms.
Main Methods:
- Biochemical characterization of mutant alleles expressed in vitro.
- Development and utilization of transgenic animal models (mice and rabbits) for FHC.
- Exploration of naturally occurring animal models of FHC.
Main Results:
- In vitro studies provided insights into the functional deficits of mutant myosin heavy chain, troponin-T, and alpha-tropomyosin alleles.
- Transgenic animal models, including a recent rabbit model, have been developed to study FHC pathogenesis.
- Natural animal models of FHC present opportunities for further research.
Conclusions:
- Understanding the molecular mechanisms of FHC pathogenesis through various research approaches is crucial.
- Discovery of additional genes and insights from animal models may lead to improved early diagnosis.
- These advancements hold promise for developing specific, mechanism-based therapeutics for FHC.
Abstract:
Familial hypertrophic cardiomyopathy (FHC) is an autosomal-dominant disease that is both clinically and genetically heterogeneous. Disease-causing mutations have been found in eight genes encoding structural components of the thick and thin filament systems of the cardiac myocyte; it has therefore been coined a disease of the sarcomere. How each mutation leads to the diverse clinical phenotypes is still obscure, and research in this area is very active. Many approaches have been used to characterize the pathogenesis of the disease. Biochemical characterization of mutant alleles expressed in vitro has shed some insight into the functional deficits of several mutant alleles of myosin heavy chain, troponin-T, and alpha-tropomyosin. Transgenic animal models for FHC have been created to gain further insight into the pathogenesis of this disease. Most of these models have been made in mice; however, recently a transgenic rabbit model has been created. In addition, there are several natural-occurring forms of FHC in animals that will be interesting to explore. The discovery of additional responsible genes and the elucidation of the molecular mechanisms of pathogenesis through the use of animal models promise improved and early diagnosis and the potential for developing specific, mutation-, or mechanism-based therapeutics.